Researchers at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Harvard’s School of Engineering and ...
Ultra-rare diseases often lack patient populations large enough to support randomized controlled trials. The question is not ...
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
“How do they do that?” is a reasonable response to certain things we see in nature. Pythons and snakes like them can eat prey as big as they are, sometimes even bigger, and digest their massive single ...
The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...
Edison Scientific will deploy its AI scientist, Kosmos, across Incyte’s drug discovery and development work. The partnership will embed Kosmos across Incyte’s translational and clinical data to ...
On May 12, 2026, the U.S. Food and Drug Administration (FDA) announced a major milestone in its approach to post-market oversight of chemicals in the food supply, finalizing a new proactive food ...
A new study shows how ERA combines large language models with tree search to rapidly build expert-level research software, outperforming leading benchmarks in tasks from single-cell genomics to ...
The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several ...
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results